David L. Brinkley, Head of Business Development at THERAVANCE INC (THRX), sold 67,032 shares at $15.65 ($1.0M) on 2010-06-14, disclosed to the SEC on 2010-06-16.
Scheduled sale ($1.0M) by Head of Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.65 | 33,516 | $525K | 50.3% |
| 2 | $15.45 | 33,516 | $518K | 49.7% |
| Total | $15.55 avg | 67,032 | $1.0M | 100% |
| Filing → |
| THRX | SELL | 2013-05-07 | $561K | — | Filing → |
| THRX | SELL | 2013-05-02 | $577K | — | Filing → |
| THRX | SELL | 2012-08-28 | $96K | — | Filing → |